TrialInternational journal of clinical oncology2020

The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Veerisa Vimolchalao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.